Internal Medicine · Somerset, NJ
NPI
1235129396
Since 2005
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
75 Veronica Ave, Ste 201
Somerset, NJ, 08873
Phone (732) 246-4882
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
125,123 services
Medicare patients, 2024
645
Average age 76
Drug cost, 2024
$2.9M
967 prescriptions
Company payments, 2025
$52.28
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Richards was code J1439 (injection, ferric carboxymaltose, 1 mg), 51,750 times for 54 patients. In total David A Richards billed 125,123 services in 121 codes, and Medicare paid $1.9M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 51,750 | 54 | $0.88 | $45K |
| J0897 Injection, denosumab, 1 mg | Office | 1,080 | 13 | $20.47 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 962 | 45 | $0.09 | $85.14 |
| 99214 Office E&M - Established | Office | 855 | 327 | $113.80 | $97K |
| 36415 Venipuncture Blood Collection | Office | 747 | 343 | $8.62 | $6,436 |
| 85025 Blood Count | Office | 392 | 144 | $7.59 | $2,976 |
| 96372 Injection Administration | Office | 337 | 103 | $12.65 | $4,264 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 320 | 19 | $0.07 | $22.89 |
| 96367 Intravenous Infusion, Hydration | Office | 313 | 71 | $27.37 | $8,567 |
| 99213 Office E&M - Established | Office | 292 | 220 | $79.89 | $23K |
| 96413 Chemotherapy Administration | Office | 200 | 66 | $123.75 | $25K |
| J9045 Injection, carboplatin, 50 mg | Office | 182 | 12 | $2.81 | $511 |
| 96365 Intravenous Infusion, Hydration | Office | 167 | 96 | $58.93 | $9,841 |
| 85027 Blood Count | Office | 166 | 62 | $6.34 | $1,052 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 147 | 80 | $14.47 | $2,128 |
By year: 2022 $2.0M for 161,957 services; 2023 $1.4M for 123,302 services; 2024 $1.9M for 125,123 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 747 | 343 | $8.62 | $6,436 |
| 85025 Blood Count | 392 | 144 | $7.59 | $2,976 |
| 85027 Blood Count | 166 | 62 | $6.34 | $1,052 |
Medicare prescription drug claims, 2024
In 2024, the drug David A Richards prescribed most often to Medicare patients was Anastrozole, with 98 prescriptions and refills. In total David A Richards wrote 967 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 98 | 284 | 33 | $2,825 |
| Aranesp Darbepoetin Alfa In Polysorbat | 65 | 65 | 13 | $141K |
| Zolpidem Tartrate Generic | 46 | 56 | Under 11 | $309 |
| Xarelto Rivaroxaban | 45 | 89 | Under 11 | $48K |
| Warfarin Sodium Generic | 44 | 120 | Under 11 | $669 |
| Neulasta Pegfilgrastim | 40 | 40 | Under 11 | $315K |
| Imbruvica Ibrutinib | 40 | 40 | Under 11 | $623K |
| Hydroxyurea Generic | 38 | 108 | Under 11 | $1,135 |
| Mvasi Bevacizumab-Awwb | 33 | 33 | Under 11 | $164K |
| Eliquis Apixaban | 30 | 48 | Under 11 | $27K |
| Lupron Depot Leuprolide Acetate | 21 | 43 | Under 11 | $85K |
| Prednisone Generic | 21 | 35 | Under 11 | $107 |
| Alprazolam Generic | 20 | 28 | Under 11 | $190 |
| Tamoxifen Citrate Generic | 17 | 51 | Under 11 | $490 |
| Herceptin Trastuzumab | 17 | 17 | Under 11 | $75K |
Brand drugs: 431 claims; generic drugs: 536 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Richards $52.28 ($52.28 in general payments such as food, travel and fees) from 3 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $19.75.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.